Short answer · Medically reviewed summary · Last updated: 2026-04-07
Lowe syndrome, also known as oculocerebrorenal syndrome of Lowe (OCRL), is a rare X-linked genetic disorder primarily characterized by congenital cataracts, intellectual disability, and renal tubular dysfunction. While medical literature may historically refer to it by various descriptive names based on its clinical presentation, Lowe syndrome remains the most widely recognized and preferred term in modern clinical practice. What are the primary synonyms and historical names for Lowe syndrome? In medical literature, you may encounter several names for Lowe syndrome, most of which were coined to describe the triad of systems affected by the condition.
Lowe syndrome, also known as oculocerebrorenal syndrome of Lowe (OCRL), is a rare X-linked genetic disorder primarily characterized by congenital cataracts, intellectual disability, and renal tubular dysfunction. While medical literature may historically refer to it by various descriptive names based on its clinical presentation, Lowe syndrome remains the most widely recognized and preferred term in modern clinical practice.
In medical literature, you may encounter several names for Lowe syndrome, most of which were coined to describe the triad of systems affected by the condition. The most common synonym is Oculocerebrorenal syndrome of Lowe, which directly highlights the involvement of the eyes (oculo), the brain (cerebro), and the kidneys (renal). Historically, older medical texts may refer to the condition simply as OCRL syndrome, which is also the official gene symbol (OCRL1) associated with the disorder. Because the condition was first described by Dr. Charles Lowe and his colleagues in 1952, it is almost universally referred to as Lowe syndrome in international medical journals and patient advocacy circles.
The variety of names stems from the historical practice of naming rare diseases after the physicians who first characterized them, combined with descriptive terminology that identifies the organs involved. As clinical understanding has evolved, the medical community has shifted toward using Lowe syndrome as the primary identifier to ensure clarity and consistency in electronic health records and clinical research. Classification systems, such as the Online Mendelian Inheritance in Man (OMIM) database, use the entry #309000 to categorize the condition, while Orphanet utilizes the identifier ORPHA545. Using the standardized term Lowe syndrome helps families and clinicians avoid confusion when navigating international databases or seeking specialized care.
Global health organizations and research databases have established specific codes to track Lowe syndrome for epidemiological and clinical purposes. These standardized identifiers are crucial for research and insurance documentation:
When communicating with healthcare providers or searching for clinical trials, it is best to use Lowe syndrome. If you are reviewing older medical records or international documentation, you may see oculocerebrorenal syndrome listed as the primary diagnosis. Regardless of the specific synonym used, the clinical management of Lowe syndrome remains focused on the multidisciplinary approach required to treat the ocular, neurological, and renal symptoms. Currently, our DiseaseMaps.org community platform includes members who are navigating these complexities, and we encourage you to use the standard terminology to ensure you are connecting with the most relevant clinical resources and peer support groups.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.